Expanded FORWARD Trial Demonstrates Continued Potential for Stem Cell-Derived Islet Cell Therapy to Eliminate Need for Insulin for People with T1D

American Diabetes Association Symposium Shows Patients with Type 1 Diabetes Experienced Insulin Independence and Elimination of Severe Hypoglycemic Events with Novel Therapy ORLANDO, Fla., June 21, 2024 /PRNewswire/ — Today, new data from the Phase 1/2 FORWARD clinical study of the…